NICOLE BOWEN: Open Payments
NPI 1811471105 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,322 in 112 payments from 25 companies in 2025. Trend: 2023 $1,011 · 2024 $1,631 · 2025 $2,322
Food & beverage: $2,267Education: $55
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $313 |
| GENZYME CORPORATION | 11 | $296 |
| JAZZ PHARMACEUTICALS INC. | 9 | $212 |
| HARMONY BIOSCIENCES LLC | 13 | $197 |
| Regeneron Healthcare Solutions, Inc. | 9 | $190 |
| GlaxoSmithKline, LLC. | 12 | $180 |
| Verona Pharma, Inc. | 9 | $138 |
| Grifols USA, LLC | 5 | $138 |
| Philips North America LLC | 4 | $83 |
| United Therapeutics Corporation | 3 | $80 |
Products named: DUPIXENT, XYWAV, WAKIX, Ohtuvayre, Prolastin-C Liquid, FASENRA, NUCALA, TRELEGY ELLIPTA.
Industry payments across MO — which companies pay providers there.
